LENZ Historical Balance Sheet

LENZ Stock

35.50 1.18 3.44%

Trend analysis of LENZ Therapeutics balance sheet accounts such as Total Current Liabilities of 4.6 M provides information on LENZ Therapeutics' total assets, liabilities, and equity, which is the actual value of LENZ Therapeutics to its prevalent stockholders. By breaking down trends over time using LENZ Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining LENZ Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether LENZ Therapeutics is a good buy for the upcoming year.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LENZ Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy LENZ Stock please use our How to Invest in LENZ Therapeutics guide.

About LENZ Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of LENZ Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. LENZ Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of LENZ Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which LENZ currently owns. An asset can also be divided into two categories, current and non-current.

LENZ Therapeutics Balance Sheet Chart

At this time, LENZ Therapeutics' Total Assets are fairly stable compared to the past year. Total Stockholder Equity is likely to rise to about 188.7 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 4 M in 2024.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Total Assets

Total assets refers to the total amount of LENZ Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in LENZ Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on LENZ Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of LENZ Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from LENZ Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into LENZ Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LENZ Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy LENZ Stock please use our How to Invest in LENZ Therapeutics guide.At this time, LENZ Therapeutics' Total Assets are fairly stable compared to the past year. Total Stockholder Equity is likely to rise to about 188.7 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 4 M in 2024.

	2023	2024 (projected)
Short and Long Term Debt Total	362K	343.9K
Total Assets	188.5M	205.7M

Short Long Term Debt Total Total Assets

LENZ Therapeutics balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Total Liab	Total Current Assets	Short Term Debt	Property Plant And Equipment Net	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Net Invested Capital	Property Plant And Equipment Gross	Capital Stock	Net Working Capital	Common Stock
Total Assets		0.43	0.35	0.32	1.0	-0.85	-0.74	0.85	1.0	-0.41	0.44	1.0	-0.83	0.78	0.29	0.72	0.97	-0.35	0.84	0.91	0.35	-0.64	0.6	0.35	0.59	-0.35
Short Long Term Debt Total	0.43		0.71	0.75	0.4	-0.18	0.08	0.24	0.4	0.27	0.81	0.41	-0.44	0.73	0.57	0.68	0.25	0.51	0.69	0.34	-0.55	0.09	-0.09	-0.53	-0.13	0.51
Other Current Liab	0.35	0.71		1.0	0.3	-0.28	-0.28	0.29	0.35	-0.05	0.93	0.35	-0.73	0.31	0.16	0.29	0.28	0.0	0.32	0.28	0.0	-0.14	0.14	0.0	0.13	0.0
Total Current Liabilities	0.32	0.75	1.0		0.26	-0.22	-0.23	0.23	0.31	-0.01	0.94	0.31	-0.7	0.33	0.22	0.32	0.23	0.06	0.31	0.23	-0.07	-0.12	0.11	-0.06	0.1	0.06
Total Stockholder Equity	1.0	0.4	0.3	0.26		-0.86	-0.73	0.86	1.0	-0.4	0.39	1.0	-0.8	0.77	0.27	0.71	0.97	-0.35	0.84	0.92	0.35	-0.62	0.6	0.36	0.59	-0.35
Net Debt	-0.85	-0.18	-0.28	-0.22	-0.86		0.66	-0.99	-0.88	0.37	-0.18	-0.88	0.72	-0.38	0.25	-0.27	-0.92	0.47	-0.72	-0.96	-0.49	0.38	-0.36	-0.48	-0.38	0.47
Retained Earnings	-0.74	0.08	-0.28	-0.23	-0.73	0.66		-0.62	-0.75	0.7	-0.32	-0.75	0.83	-0.32	-0.05	-0.35	-0.81	0.8	-0.26	-0.58	-0.85	0.92	-0.89	-0.84	-0.9	0.8
Cash	0.85	0.24	0.29	0.23	0.86	-0.99	-0.62		0.88	-0.26	0.2	0.88	-0.7	0.43	-0.21	0.31	0.92	-0.37	0.77	0.96	0.41	-0.33	0.34	0.43	0.36	-0.37
Cash And Short Term Investments	1.0	0.4	0.35	0.31	1.0	-0.88	-0.75	0.88		-0.4	0.42	1.0	-0.83	0.74	0.23	0.68	0.98	-0.36	0.84	0.93	0.37	-0.62	0.59	0.38	0.58	-0.36
Common Stock Shares Outstanding	-0.41	0.27	-0.05	-0.01	-0.4	0.37	0.7	-0.26	-0.4		-0.08	-0.41	0.48	-0.07	0.04	-0.11	-0.44	0.89	0.01	-0.37	-0.72	0.72	-0.47	-0.55	-0.48	0.89
Total Liab	0.44	0.81	0.93	0.94	0.39	-0.18	-0.32	0.2	0.42	-0.08		0.42	-0.74	0.57	0.52	0.58	0.31	0.08	0.39	0.24	-0.09	-0.31	0.3	-0.08	0.27	0.08
Total Current Assets	1.0	0.41	0.35	0.31	1.0	-0.88	-0.75	0.88	1.0	-0.41	0.42		-0.83	0.75	0.24	0.69	0.98	-0.36	0.84	0.92	0.37	-0.62	0.59	0.38	0.59	-0.36
Short Term Debt	-0.83	-0.44	-0.73	-0.7	-0.8	0.72	0.83	-0.7	-0.83	0.48	-0.74	-0.83		-0.53	-0.17	-0.52	-0.82	0.48	-0.54	-0.69	-0.5	0.68	-0.65	-0.5	-0.65	0.48
Property Plant And Equipment Net	0.78	0.73	0.31	0.33	0.77	-0.38	-0.32	0.43	0.74	-0.07	0.57	0.75	-0.53		0.78	0.99	0.62	0.19	0.83	0.57	-0.21	-0.41	0.4	-0.19	0.36	0.19
Accounts Payable	0.29	0.57	0.16	0.22	0.27	0.25	-0.05	-0.21	0.23	0.04	0.52	0.24	-0.17	0.78		0.86	0.08	0.36	0.32	-0.06	-0.38	-0.35	0.34	-0.36	0.28	0.36
Non Current Assets Total	0.72	0.68	0.29	0.32	0.71	-0.27	-0.35	0.31	0.68	-0.11	0.58	0.69	-0.52	0.99	0.86		0.55	0.16	0.72	0.45	-0.18	-0.49	0.47	-0.16	0.43	0.16
Non Currrent Assets Other	0.97	0.25	0.28	0.23	0.97	-0.92	-0.81	0.92	0.98	-0.44	0.31	0.98	-0.82	0.62	0.08	0.55		-0.48	0.75	0.92	0.52	-0.65	0.64	0.53	0.64	-0.48
Other Assets	-0.35	0.51	0.0	0.06	-0.35	0.47	0.8	-0.37	-0.36	0.89	0.08	-0.36	0.48	0.19	0.36	0.16	-0.48		0.15	-0.35	-0.95	0.7	-0.56	-0.85	-0.6	1.0
Non Current Liabilities Total	0.84	0.69	0.32	0.31	0.84	-0.72	-0.26	0.77	0.84	0.01	0.39	0.84	-0.54	0.83	0.32	0.72	0.75	0.15		0.85	-0.17	-0.14	0.13	-0.15	0.11	0.15
Other Current Assets	0.91	0.34	0.28	0.23	0.92	-0.96	-0.58	0.96	0.93	-0.37	0.24	0.92	-0.69	0.57	-0.06	0.45	0.92	-0.35	0.85		0.31	-0.36	0.29	0.29	0.3	-0.35
Other Stockholder Equity	0.35	-0.55	0.0	-0.07	0.35	-0.49	-0.85	0.41	0.37	-0.72	-0.09	0.37	-0.5	-0.21	-0.38	-0.18	0.52	-0.95	-0.17	0.31		-0.73	0.69	0.97	0.73	-0.95
Net Invested Capital	-0.64	0.09	-0.14	-0.12	-0.62	0.38	0.92	-0.33	-0.62	0.72	-0.31	-0.62	0.68	-0.41	-0.35	-0.49	-0.65	0.7	-0.14	-0.36	-0.73		-0.94	-0.71	-0.94	0.7
Property Plant And Equipment Gross	0.6	-0.09	0.14	0.11	0.6	-0.36	-0.89	0.34	0.59	-0.47	0.3	0.59	-0.65	0.4	0.34	0.47	0.64	-0.56	0.13	0.29	0.69	-0.94		0.75	1.0	-0.56
Capital Stock	0.35	-0.53	0.0	-0.06	0.36	-0.48	-0.84	0.43	0.38	-0.55	-0.08	0.38	-0.5	-0.19	-0.36	-0.16	0.53	-0.85	-0.15	0.29	0.97	-0.71	0.75		0.79	-0.85
Net Working Capital	0.59	-0.13	0.13	0.1	0.59	-0.38	-0.9	0.36	0.58	-0.48	0.27	0.59	-0.65	0.36	0.28	0.43	0.64	-0.6	0.11	0.3	0.73	-0.94	1.0	0.79		-0.6
Common Stock	-0.35	0.51	0.0	0.06	-0.35	0.47	0.8	-0.37	-0.36	0.89	0.08	-0.36	0.48	0.19	0.36	0.16	-0.48	1.0	0.15	-0.35	-0.95	0.7	-0.56	-0.85	-0.6

Click cells to compare fundamentals

LENZ Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for LENZ Stock Analysis

When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

LENZ Historical Balance Sheet

About LENZ Balance Sheet Analysis

LENZ Therapeutics Balance Sheet Chart

Total Assets

Total Current Liabilities

LENZ Therapeutics balance sheet Correlations

LENZ Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for LENZ Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity

Cash	- 0.99	Net Debt
Other Current Assets	- 0.96	Net Debt
Common Stock	- 0.95	Other Stockholder Equity
Other Stockholder Equity	- 0.95	Other Assets
Net Working Capital	- 0.94	Net Invested Capital
Property Plant And Equipment Gross	- 0.94	Net Invested Capital